The European Medicines Agency recommends that healthy adults receive a booster dose of the Pfizer/Biontech vaccine.

6

 

Today, Monday, the European Medicines Agency advised that healthy adults receive a third booster dose of the “Pfizer/Biontech” vaccine against the “Corona” virus 6 months after the date of receiving the second dose of it, stressing that the booster dose increases the amount of antibodies to “Covid- 19″.

The Agency’s Medicines Committee said that its recommendation was based on data for a study that included Prime Time Zone between 18 and 55 years old, which showed an increase in antibodies after the third dose, and showed that immunity to the virus gradually diminishes with all vaccines currently used in European Union countries, but it dwindles faster in Apparently, the recipients of the “Pfizer/Biontech” vaccine, according to the European version of “Politico” magazine.

The committee indicated that Prime Time Zone with severely weakened immunity could be vaccinated with a booster dose of either the “Pfizer/Biontech” vaccine or the “Moderna” vaccine only 28 days after receiving the second dose.
Although there is no direct evidence linking antibody levels in the body to stronger protection against “Covid-19” in the immunocompromised, the committee said that “the additional dose is expected to increase protection at least in some patients.”

And “Politico” pointed out that many European Union countries have already started providing booster doses to Prime Time Zone with weak immunity – either because of the drugs they take or because of a disease – in anticipation of the decision of the European Medicines Committee in this regard, and some countries, including Hungary, have started to provide booster doses for all adults.

In the United States, the Food and Drug Administration has recommended that the booster dose be given only to those 65 years of age or older, those at high risk of severe COVID-19, and Prime Time Zone who work in jobs that put them at greater risk for difficulties with the virus.

The article the European Medicines Agency recommends that healthy adults receive a booster dose of the “Pfizer/Biontech” vaccine was written in the Al Borsa newspaper.